Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

What makes a good-quality GP report for an Initial Child Protection Conference?

Gibson J, Racioppi M, Nembhard-Francis J.

Br J Gen Pract. 2019 Oct 31;69(688):577-578. doi: 10.3399/bjgp19X706529. Print 2019 Nov. No abstract available.

PMID:
31672832
2.

Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer.

Racioppi M, Di Gianfrancesco L, Ragonese M, Palermo G, Sacco E, Bassi P.

Eur Urol Oncol. 2019 Sep;2(5):576-583. doi: 10.1016/j.euo.2018.08.032. Epub 2018 Oct 6.

PMID:
31411974
3.

Circulating tumor cells as prognostic biological marker in different stages prostate cancer and the effect of different therapeutic approaches on their expression.

Palermo G, Bassi P, Racioppi M, Recupero SM, Sacco E, Campetella M, Canu G, Pinto F.

Minerva Urol Nefrol. 2019 May 28. doi: 10.23736/S0393-2249.19.03377-0. [Epub ahead of print]

PMID:
31144490
4.

Can Neutrophil-to-Lymphocyte ratio predict the response to BCG in high-risk non muscle invasive bladder cancer?

Racioppi M, Di Gianfrancesco L, Ragonese M, Palermo G, Sacco E, Bassi PF.

Int Braz J Urol. 2019 Mar-Apr;45(2):315-324. doi: 10.1590/S1677-5538.IBJU.2018.0249.

5.

ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk "BCG failure" non muscle invasive bladder cancer: 3 years follow-up outcomes.

Racioppi M, Di Gianfrancesco L, Ragonese M, Palermo G, Sacco E, Bassi PF.

BMC Cancer. 2018 Dec 6;18(1):1224. doi: 10.1186/s12885-018-5134-7.

6.

Quality of life following urinary diversion: Orthotopic ileal neobladder versus ileal conduit. A multicentre study among long-term, female bladder cancer survivors.

Siracusano S, D'Elia C, Cerruto MA, Gacci M, Ciciliato S, Simonato A, Porcaro A, De Marco V, Talamini R, Toffoli L, Saleh O, Serni S, Visalli F, Niero M, Lonardi C, Imbimbo C, Verze P, Mirone V, Racioppi M, Iafrate M, Cacciamani G, De Marchi D, Bassi P, Artibani W.

Eur J Surg Oncol. 2019 Mar;45(3):477-481. doi: 10.1016/j.ejso.2018.10.061. Epub 2018 Oct 21.

PMID:
30385155
7.

Non-β-Blocking Carvedilol Analog, VK-II-86, Prevents Ouabain-Induced Cardiotoxicity.

Gonano LA, Sepúlveda M, Morell M, Toteff T, Racioppi MF, Lascano E, Negroni J, Fernández Ruocco MJ, Medei E, Neiman G, Miriuka SG, Back TG, Chen SRW, Mattiazzi A, Vila Petroff M.

Circ J. 2018 Dec 25;83(1):41-51. doi: 10.1253/circj.CJ-18-0247. Epub 2018 Oct 23.

8.

Patient pad count is a poor measure of urinary incontinence compared with 48-h pad test: results of a large-scale multicentre study.

Sacco E, Bientinesi R, Gandi C, Di Gianfrancesco L, Pierconti F, Racioppi M, Bassi P.

BJU Int. 2019 May;123(5A):E69-E78. doi: 10.1111/bju.14566. Epub 2018 Oct 19.

PMID:
30253042
9.

The challenges of Bacillus of Calmette-Guerin (BCG) therapy for high risk non muscle invasive bladder cancer treatment in older patients.

Racioppi M, Di Gianfrancesco L, Ragonese M, Palermo G, Sacco E, Bassi P.

J Geriatr Oncol. 2018 Sep;9(5):507-512. doi: 10.1016/j.jgo.2018.03.020. Epub 2018 Apr 16.

PMID:
29673806
10.

Health-Related Quality of Life after Radical Cystectomy for Bladder Cancer in Elderly Patients with Ileal Orthotopic Neobladder or Ileal Conduit: Results from a Multicentre Cross-Sectional Study Using Validated Questionnaires.

Cerruto MA, D'Elia C, Siracusano S, Saleh O, Gacci M, Cacciamani G, De Marco V, Porcaro AB, Balzarro M, Niero M, Lonardi C, Iafrate M, Bassi P, Imbimbo C, Racioppi M, Talamini R, Ciciliato S, Serni S, Carini M, Verze P, Artibani W.

Urol Int. 2018;100(3):346-352. doi: 10.1159/000487644. Epub 2018 Mar 7.

PMID:
29514144
11.

Titanized Transobturator Sling Placement for Male Stress Urinary Incontinence Using an Inside-out Single-incision Technique: Minimum 12-Months Follow-up Study.

Sacco E, Gandi C, Vaccarella L, Recupero S, Racioppi M, Pinto F, Totaro A, Foschi N, Palermo G, Pierconti F, Bassi P.

Urology. 2018 May;115:144-150. doi: 10.1016/j.urology.2018.02.022. Epub 2018 Mar 1.

PMID:
29501713
12.

Quality of Life in Patients with Bladder Cancer Undergoing Ileal Conduit: A Comparison of Women Versus Men.

Siracusano S, D'Elia C, Cerruto MA, Saleh O, Serni S, Gacci M, Ciciliato S, Simonato A, Porcaro A, DE Marco V, Talamini R, Toffoli L, Visalli F, Niero M, Lonardi C, Imbimbo C, Verze P, Mirone V, Racioppi M, Iafrate M, Cacciamani G, DE Marchi D, Bassi P, Artibani W.

In Vivo. 2018 Jan-Feb;32(1):139-143.

13.

Neoadjuvant Chemotherapy for Patients with Muscle-invasive Urothelial Bladder Cancer Candidates for Curative Surgery: A Prospective Clinical Trial Based on Cisplatin Feasibility.

Schinzari G, Monterisi S, Pierconti F, Nazzicone G, Marandino L, Orlandi A, Racioppi M, Cassano A, Bassi P, Barone C, Rossi E.

Anticancer Res. 2017 Nov;37(11):6453-6458.

PMID:
29061832
14.

Intraprostatic botulinum toxin type "A" injection in patients with benign prostatic hyperplasia and unsatisfactory response to medical therapy: A randomized, double-blind, controlled trial using urodynamic evaluation.

Totaro A, Pinto F, Pugliese D, Vittori M, Racioppi M, Foschi N, Bassi PF, Sacco E.

Neurourol Urodyn. 2018 Mar;37(3):1031-1038. doi: 10.1002/nau.23390. Epub 2017 Aug 25.

PMID:
28840969
15.

Is Health-Related Quality of Life after Radical Cystectomy Using Validated Questionnaires Really Better in Patients with Ileal Orthotopic Neobladder Compared to Ileal Conduit: A Meta-Analysis of Retrospective Comparative Studies.

Cerruto MA, D'Elia C, Siracusano S, Porcaro AB, Cacciamani G, De Marchi D, Niero M, Lonardi C, Iafrate M, Bassi P, Belgrano E, Imbimbo C, Racioppi M, Talamini R, Ciciliato S, Toffoli L, Rizzo M, Visalli F, Verze P, Artibani W.

Curr Urol. 2017 Jul;10(2):57-68. doi: 10.1159/000447153. Epub 2017 May 30. Review.

16.

Health-related Quality of Life After Radical Cystectomy: A Cross-sectional Study With Matched-pair Analysis on Ileal Conduit vs Ileal Orthotopic Neobladder Diversion.

Cerruto MA, D'Elia C, Siracusano S, Saleh O, Gacci M, Cacciamani G, De Marco V, Porcaro AB, Balzarro M, Niero M, Lonardi C, Iafrate M, Bassi P, Imbimbo C, Racioppi M, Talamini R, Ciciliato S, Serni S, Carini M, Verze P, Artibani W.

Urology. 2017 Oct;108:82-89. doi: 10.1016/j.urology.2017.06.022. Epub 2017 Jun 23.

PMID:
28652163
17.

High intensity focused ultrasound as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes.

Palermo G, Totaro A, Sacco E, Foschi N, Gulino G, Racioppi M, Bassi P, Pinto F.

Minerva Urol Nefrol. 2017 Feb;69(1):93-100. doi: 10.23736/S0393-2249.16.02696-5. Epub 2016 Sep 28.

PMID:
28009150
18.

Mitomycin C: new strategies to improve efficacy of a well-known therapy.

Ragonese M, Racioppi M, Bassi PF, Di Gianfrancesco L, Lenci N, Filianoti A, Recupero SM.

Urologia. 2016 Oct 4;83(Suppl 2):24-28. doi: 10.5301/uro.5000193. Epub 2016 Oct 1. Review.

PMID:
27647081
19.

Postoperative Quality of Life in Patients with Ileal Neobladder at Short-, Intermediate- and Long-Term Follow-Up.

D''Agostino D, Racioppi M, Pugliese D, Ragonese M, Di Gianfrancesco L, Filianoti A, Palermo G, Belgrano E, Siracusano S, Niero M, Imbimbo C, Iafrate M, Artibani W, Cerruto MA, Talamini R, Bassi P.

Urol Int. 2016;97(1):54-60. doi: 10.1159/000443185. Epub 2016 Apr 12.

PMID:
27064910
20.

Systematic review and meta-analysis of non RCT's on health related quality of life after radical cystectomy using validated questionnaires: Better results with orthotopic neobladder versus ileal conduit.

Cerruto MA, D'Elia C, Siracusano S, Gedeshi X, Mariotto A, Iafrate M, Niero M, Lonardi C, Bassi P, Belgrano E, Imbimbo C, Racioppi M, Talamini R, Ciciliato S, Toffoli L, Rizzo M, Visalli F, Verze P, Artibani W.

Eur J Surg Oncol. 2016 Mar;42(3):343-60. doi: 10.1016/j.ejso.2015.10.001. Epub 2015 Nov 9. Review.

PMID:
26620844
21.

The occult urothelial cancer.

Ragonese M, Racioppi M, D'Agostino D, Di Gianfrancesco L, Lenci N, Bientinesi R, Palermo G, Sacco E, Pinto F, Bassi PF.

Urologia. 2016 May 24;83(2):55-60. doi: 10.5301/uro.5000131. Epub 2016 Mar 14. Review.

PMID:
26481721
22.

NBI: results review.

Racioppi M, D'Agostino D, Ragonese M, Gianfrancesco LD, Bassi PF.

Urologia. 2015 Oct;82 Suppl 2:S9-11. doi: 10.5301/uro.5000155. Epub 2015 Oct 9. Review.

PMID:
26481720
23.

Quality of Life Assessment With Orthotopic Ileal Neobladder Reconstruction After Radical Cystectomy: Results From a Prospective Italian Multicenter Observational Study.

Imbimbo C, Mirone V, Siracusano S, Niero M, Cerruto MA, Lonardi C, Artibani W, Bassi P, Iafrate M, Racioppi M, Talamini R, Ciciliato S, Toffoli L, Visalli F, Massidda D, D'Elia C, Cacciamani G, De Marchi D, Silvestri T, Creta M, Belgrano E, Verze P.

Urology. 2015 Nov;86(5):974-9. doi: 10.1016/j.urology.2015.06.058. Epub 2015 Aug 18.

PMID:
26291562
24.

Endourethral migration of a Hem-o-Lok Clip after robot-assisted laparoscopic radical prostatectomy.

Bientinesi R, Di Gianfrancesco L, Pugliese D, D'Agostino D, Racioppi M, Bassi PF, Sacco E.

Urologia. 2015 Oct-Dec;82(4):242-4. doi: 10.5301/uro.5000106. Epub 2014 Dec 16.

PMID:
25589027
25.

[Antibiotic prophylaxis in urology].

Recupero SM, Bientinesi R, Foschi N, Racioppi M, Bassi PF, Sacco E.

Urologia. 2014 Oct-Dec;81(4):209-17. doi: 10.5301/uro.5000098. Epub 2014 Dec 5. Review. Italian.

PMID:
25532466
26.

Concordance and clinical significance of uncommon variants of bladder urothelial carcinoma in transurethral resection and radical cystectomy specimens.

Cai T, Tiscione D, Verze P, Pomara G, Racioppi M, Nesi G, Barbareschi M, Brausi M, Gacci M, Luciani LG, Liguori G, Gontero P, Campodonico F, Simonato A, Boddi V, Di Stasi SM, Colombo R, Serretta V, Carmignani G, Malossini G, Altieri V, Carini M, Terrone C, Bassi P, Montorsi F, Ficarra V, Selli C, Mirone V, Bartoletti R.

Urology. 2014 Nov;84(5):1141-6. doi: 10.1016/j.urology.2014.06.032. Epub 2014 Sep 18.

PMID:
25239253
27.

[Male infertility: non-surgical therapy].

Gulino G, Stefanucci M, Antonucci M, Racioppi M, Sacco E, Pinto F, Bassi PF.

Urologia. 2014 Jul-Sep;81(3):148-53. doi: 10.5301/uro.5000087. Epub 2014 Sep 1. Review. Italian.

PMID:
25198940
28.

Development of a questionnaire specifically for patients with Ileal Orthotopic Neobladder (IONB).

Siracusano S, Niero M, Lonardi C, Cerruto MA, Ciciliato S, Toffoli L, Visalli F, Massidda D, Iafrate M, Artibani W, Bassi P, Imbimbo C, Racioppi M, Talamini R, D'Elia C, Cacciamani G, De Marchi D, Silvestri T, Verze P, Belgrano E.

Health Qual Life Outcomes. 2014 Sep 1;12:135. doi: 10.1186/s12955-014-0135-y.

29.

The clinical use of statistical permutation test methodology: a tool for identifying predictive variables of outcome.

Racioppi M, Salmaso L, Brombin C, Arboretti R, D'Agostino D, Colombo R, Serretta V, Brausi M, Casetta G, Gontero P, Hurle R, Tenaglia R, Altieri V, Bartoletti R, Maffezzini M, Siracusano S, Morgia G, Bassi PF.

Urol Int. 2015;94(3):262-9. doi: 10.1159/000365292. Epub 2014 Aug 27.

PMID:
25171377
30.

Behavioural profile and human adaptation of survivors after radical cystectomy and ileal conduit.

Cerruto MA, D'Elia C, Cacciamani G, De Marchi D, Siracusano S, Iafrate M, Niero M, Lonardi C, Bassi P, Belgrano E, Imbimbo C, Racioppi M, Talamini R, Ciciliato S, Toffoli L, Rizzo M, Visalli F, Verze P, Artibani W.

Health Qual Life Outcomes. 2014 Apr 7;12:46. doi: 10.1186/1477-7525-12-46.

31.

Discovery history and clinical development of mirabegron for the treatment of overactive bladder and urinary incontinence.

Sacco E, Bientinesi R, Tienforti D, Racioppi M, Gulino G, D'Agostino D, Vittori M, Bassi P.

Expert Opin Drug Discov. 2014 Apr;9(4):433-48. doi: 10.1517/17460441.2014.892923. Epub 2014 Feb 22. Review.

PMID:
24559030
32.

Sexual outcomes after organ potency-sparing surgery and glans reconstruction in patients with penile carcinoma.

Gulino G, Sasso F, Palermo G, D'Onofrio A, Racioppi M, Sacco E, Pinto F, Antonucci M, D'Addessi A, Bassi P.

Indian J Urol. 2013 Apr;29(2):119-23. doi: 10.4103/0970-1591.114033.

33.

OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes.

Sacco E, Tienforti D, Bientinesi R, D'Addessi A, Racioppi M, Pinto F, Totaro A, Vittori M, D'Agostino D, Bassi P.

Neurourol Urodyn. 2014 Jan;33(1):142-6. doi: 10.1002/nau.22393. Epub 2013 Jul 19.

PMID:
23868794
34.

[Innovative treatments of non muscle invasive bladder cancer].

Racioppi M, D'Agostino D, Pugliese D, Ragonese M, Di Gianfrancesco L, Bassi P.

Urologia. 2013 Apr-Jun;80(2):120-6. doi: 10.5301/RU.2013.11302. Epub 2013 Jul 5. Italian.

PMID:
23852929
35.

HER-2 immunohistochemical expression as prognostic marker in high-grade T1 bladder cancer (T1G3).

Bongiovanni L, Arena V, Vecchio FM, Racioppi M, Bassi P, Pierconti F.

Arch Ital Urol Androl. 2013 Jun 24;85(2):73-7. doi: 10.4081/aiua.2013.2.73.

36.

[Second-line intravesical therapy. What is the present role of device-assisted therapy?].

Racioppi M, D'Agostino D, Gianfrancesco LD, Bassi PF.

Urologia. 2013;80 Suppl 21:37-41. doi: 10.5301/RU.2013.10863. Epub 2013 Mar 22. Italian.

PMID:
23559138
37.

[Therapeutic strategies in penile cancer: state of the art].

Gulino G, Palermo G, Antonucci M, Racioppi M, Pinto F, Sacco E, Bassi PF.

Urologia. 2013 Jan-Mar;80(1):1-10. doi: 10.5301/RU.2013.10909. Epub 2013 Apr 4. Italian.

PMID:
23559129
38.

Size of bladder cancers: correlation among different types of measurement.

Racioppi M, Cappa E, D'Agostino D, Filianoti A, Pugliese D, Cadeddu C, De Wore C, Sacco E, Pinto F, D'Addessi A, Ghera P, Bassi PF.

Urol Int. 2013;90(2):191-4. doi: 10.1159/000343666. Epub 2012 Nov 6.

PMID:
23147255
39.

High-intensity focused ultrasound in prostate cancer: today's outcomes and tomorrow's perspectives.

Palermo G, Pinto F, Totaro A, Miglioranza E, Calarco A, Sacco E, Daddessi A, Vittori M, Racioppi M, Dagostino D, Gulino G, Giustacchini M, Bassi P.

Scand J Urol. 2013 Jun;47(3):179-87. doi: 10.3109/00365599.2012.721393. Epub 2012 Sep 19. Review.

PMID:
22989087
40.

Thermochemotherapy for non-muscle-invasive bladder cancer: is there a chance to avoid early cystectomy?.

Volpe A, Racioppi M, Bongiovanni L, D'Agostino D, Totaro A, D'Addessi A, Marangi F, Palermo G, Pinto F, Sacco E, Bassi PF.

Urol Int. 2012;89(3):311-8. doi: 10.1159/000341912. Epub 2012 Sep 7.

PMID:
22965159
41.

Hot topics in urological health economics. A mini review.

Racioppi M, Palermo G, D'Addessi A, Pinto F, Sacco E, D'Agostino D, Vittori M, Bassi PF.

Arch Ital Urol Androl. 2012 Jun;84(2):47-52. Review.

PMID:
22908771
42.

Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.

Sacco E, Bientinesi R, Marangi F, Totaro A, D'Addessi A, Racioppi M, Pinto F, Vittori M, Bassi P.

BJU Int. 2012 Dec;110(11 Pt C):E837-44. doi: 10.1111/j.1464-410X.2012.11288.x. Epub 2012 Jun 19.

43.

[Therapy for non-muscle invasive bladder cancer: HP-NAP].

D'Agostino D, Racioppi M, Filianoti A, Di Gianfrancesco L, Codolo G, Fassan M, Munari F, Rugge M, D'Elios MM, de Bernard M, Pagano F, Bassi P.

Urologia. 2012 Apr-Jun;79(2):142-8. doi: 10.5301/RU.2012.9189. Italian.

PMID:
22522462
44.

Bradeion (SEPT4) as a urinary marker of transitional cell bladder cancer: a real-time polymerase chain reaction study of gene expression.

Bongiovanni L, Pirozzi F, Guidi F, Orsini M, Chiurazzi P, Bassi PF, Racioppi M.

J Urol. 2012 Jun;187(6):2223-7. doi: 10.1016/j.juro.2012.01.031. Epub 2012 Apr 13.

PMID:
22503047
45.

Complications of extracorporeal shock wave lithotripsy for urinary stones: to know and to manage them-a review.

D'Addessi A, Vittori M, Racioppi M, Pinto F, Sacco E, Bassi P.

ScientificWorldJournal. 2012;2012:619820. doi: 10.1100/2012/619820. Epub 2012 Mar 12. Review.

46.

[Robot technology in the Italian Health-CARE system: cost-efficacy economic analysis].

Gulino G, Antonucci M, Palermo G, D'Agostino D, D'Addessi A, Racioppi M, Pinto F, Sacco E, Bassi P.

Urologia. 2012 Apr-Jun;79(2):69-80. doi: 10.5301/RU.2012.9098. Review. Italian.

PMID:
22388991
47.

Bladder pain syndrome associated with highest impact on sexual function among women with lower urinary tract symptoms.

Sacco E, D'Addessi A, Racioppi M, Pinto F, Totaro A, Bassi P.

Int J Gynaecol Obstet. 2012 May;117(2):168-72. doi: 10.1016/j.ijgo.2011.12.015. Epub 2012 Feb 22.

PMID:
22361478
48.

Value of current chemotherapy and surgery in advanced and metastatic bladder cancer.

Racioppi M, D'Agostino D, Totaro A, Pinto F, Sacco E, D'Addessi A, Marangi F, Palermo G, Bassi PF.

Urol Int. 2012;88(3):249-58. doi: 10.1159/000335556. Epub 2012 Feb 17. Review.

49.

Efficacy of an assisted low-intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial.

Tienforti D, Sacco E, Marangi F, D'Addessi A, Racioppi M, Gulino G, Pinto F, Totaro A, D'Agostino D, Bassi P.

BJU Int. 2012 Oct;110(7):1004-10. doi: 10.1111/j.1464-410X.2012.10948.x. Epub 2012 Feb 14.

50.

Imaging in prostate cancer staging: present role and future perspectives.

Pinto F, Totaro A, Palermo G, Calarco A, Sacco E, D'Addessi A, Racioppi M, Valentini A, Gui B, Bassi P.

Urol Int. 2012;88(2):125-36. doi: 10.1159/000335205. Epub 2012 Jan 27. Review.

Supplemental Content

Loading ...
Support Center